CytomX Therapeutics: Q3 Earnings Snapshot
CytomX Therapeutics: Q2 Earnings Snapshot
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of 68.75% and 5.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
CytomX Therapeutics: Q1 Earnings Snapshot
Codexis (CDXS) delivered earnings and revenue surprises of -17.24% and 11.34%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Certara, Inc. (CERT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CytomX Therapeutics (CTMX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stocks that traded heavily or had substantial price changes Tuesday: Walgreens, McCormick rise; Invesco Mortgage, CytomX fall
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -100% and 94.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
FN Media Group Presents USA News Group News Commentary  Vancouver, BC – March 24, 2023 – USA News Group  – Treatments for various forms of breast cancer continue to evolve, with several new...